Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT00326690Not ApplicableWithdrawn
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more
Principalinvestigator

Research Network

Collaboration Network

34 collaborators·78 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Volkmar Falk, MD

Heart Center Leipzig

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Erika Feller, MD

University of Maryland College of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

James D. Bergin, MD

University of Virginia College of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Howard J Eisen, MD

Drexel University College of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Francis Pagani, MD

University of Michigan

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Ernst Schwarz, MD

Cedar Sinai Department of Cardiothoracic Surgery

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Ulrich Jorde, MD

New York College of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Robert R. Lazzara, MD

St. Joseph's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Rosemary Peterson, MD

St. Joseph's Hospital - Tacoma, WA

Moderately Similar
1 trials

Shared therapeutic areas:

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more

Worked with same sponsors:

BioVentrix
Collaborated on 1 trial
Similarity Score44%

Paul J. Hauptman, MD

St. Louis University Hospital

Related
1 trials

Shared therapeutic areas:

Cardiomyopathy, DilatedCongestive Heart Failure

Worked with same sponsors:

Celladon Corporation
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00326690Not ApplicablePrincipalInvestigator

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Congestive Heart FailureCoronary Artery DiseaseIschemic Cardiomyopathy+1 more
Withdrawn
NCT00454818Phase 1/2StudyChair

Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Dilated CardiomyopathyHeart Failure, Congestive
Completed

All 2 trials loaded